Glenmark Pharmaceuticals, a research-led integrated global pharmaceutical company, announced that it has initiated Phase 3 clinical trials in India on Antiviral tablet Favipiravir, for which it received approval from India’s drug regulator DCGI in late April. Glenmark claims to be the first company in India to initiate Phase 3 clinical trials on Favipiravir for COVID-19…